Table 1.

Assessment time points for primary and secondary outcomes of SMART-CR/SP study

Outcome	Assessment	Baseline	8 week	6 month	12 month
Primary outcome
Exercise capacity	Change in 6MWT distance	✔	✔	✔
Key secondary outcome
Knowledge of the disease	Modified CHD questionnaire42 43	✔	✔	✔	✔
Secondary outcomes
Blood pressure	Average of two resting, sitting digital recordings	✔	✔	✔
Lipid profile	Fasting blood sample	✔	✔	✔	✔
Medication adherence	Adherent to cardiac-protective medications	✔	✔	✔	✔
Smoking	Self-report	✔	✔	✔	✔
Obesity	Weight, height, waist and hip circumference	✔	✔	✔
Physical activity	General Physical Activity Questionnaire46	✔	✔	✔	✔
Fruit and vegetable intake	WHO Steps instrument44	✔	✔	✔	✔
Anxiety symptoms	Generalised Anxiety Disorder 7-item (GAD-7) scale47	✔	✔	✔	✔
Depressive symptoms	Patient Health Questionnaire (PHQ-9)48	✔	✔	✔	✔
Quality of life	SF-12_V2 Health Survey49	✔	✔	✔	✔
CV events	CVD death, non-fatal AMI, stroke or hospital admission with unstable angina or congestive heart failure		✔	✔	✔
CR/SP needs survey	Patient needs for the core components of CR/SP33	✔	✔	✔	✔
All-cause mortality	Data from CDC		✔	✔	✔

AMI, acute myocardial infarction; BP, blood pressure; CDC, Centre Disease Control and Prevention; CHD, coronary heart disease; CR/SP, cardiac rehabilitation and secondary prevention; CV, cardiovascular; LDL, low-density lipoprotein; 6 MWT, 6  min walk test distance.